Stock data
Abeona Therapeutics Inc. (ABEO)
Abeona Therapeutics Inc. (ABEO) reported revenue of US$5.82M and net income of US$71.18M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$5.82M | — | -US$89.45M | US$71.18M | — |
| 2024 | — | — | -US$64.21M | -US$63.73M | — |
| 2023 | US$3.50M | — | -US$47.13M | -US$54.19M | — |
| 2022 | US$1.41M | — | -US$50.91M | -US$39.70M | — |
| 2021 | US$3.00M | — | -US$89.84M | -US$84.94M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$11.38M | -US$20.19M | — |
| 2026-03-31 | US$8.72M | -US$17.07M | — |
| 2025-12-31 | — | -US$20.46M | — |
| 2025-09-30 | — | -US$5.16M | — |
| 2025-06-30 | US$0.40M | US$108.83M | — |
| 2025-03-31 | — | -US$12.03M | — |
| 2024-12-31 | — | -US$9.29M | — |
| 2024-09-30 | — | -US$30.27M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.